The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases

摘要

The present invention is concerned with the use of individual administration forms of an erythropoietin preparation and a physiologically compatible iron preparation corresponding to an equivalent amount of 1-40 mg of iron ions for the production of a pharmaceutical combination preparation for the treatment of rheumatic diseases.